Lactobacillus Plantarum for Psoriasis: Safety and Effectiveness Study
Part of Skin clinical trials.
This trial tests whether a probiotic called Lactobacillus plantarum can safely help treat psoriasis. It's a randomized, double-blind study where some participants get the probiotic and others get a placebo, so no one knows who gets what.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mild to moderate psoriasis with a PASI score less than 10.
- You are between 18 and 60 years old and in good general health.
- You have not taken any psoriasis medications in the last 6 months.
- You do not have other inflammatory skin diseases, infections, or neuromuscular diseases.
- You are not in the active phase of another skin disease or have other serious illnesses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This study tests a new oral medication for psoriasis in healthy volunteers to check its safety and how the body handles it. It is an early-phase trial to gather information before testing in patients.
This trial tests a new study drug (ZP9830) to see if it is safe and works well for people with plaque psoriasis. You would receive the treatment for 8 weeks, and the study will check how your skin responds.
This pilot study tests whether adding probiotics to standard methotrexate treatment improves symptoms in people newly diagnosed with chronic plaque psoriasis. It aims to see how the gut microbiome affects treatment response.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.